Method of treating cancer with a combination of MER tyrosine kinase inhibitor and an epidermal growth factor receptor (EGFR) inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10709708
APP PUB NO 20170266188A1
SERIAL NO

15462299

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides combinations comprising a MERTK inhibitor, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor and methods of use thereof, including methods of treating disorders such as cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EMORY UNIVERSITY1599 CLIFTON ROAD NE 4TH FLOOR ATLANTA GA 30322

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DeRyckere, Deborah Ann Atlanta, US 1 1
Earp,, III H Shelton Chapel Hill, US 2 1
Graham, Douglas Kim Atlanta, US 8 48
Wan, Jing Chapel Hill, US 45 672
Yan, Dan Lilburn, US 14 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 14, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 14, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00